Our finding is consistent with predecessor's studies and confirmed that ICA suppressed the tumor progression of cervical cancer by inhibiting TLR4/MyD88/NF-κB and Wnt/β-catenin pathways in vitro and in vivo. Here, TLR4 is linked to neoplasm.